|
HNRNPA3P1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62669877568078E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73361325295218E-12 |
| Normal-vs-Stage2 |
5.2259999994142E-08 |
| Normal-vs-Stage3 |
5.69509994718942E-11 |
| Normal-vs-Stage4 |
1.74749104076E-12 |
| Stage1-vs-Stage2 |
4.348200E-01 |
| Stage1-vs-Stage3 |
3.477800E-01 |
| Stage1-vs-Stage4 |
5.623500E-03 |
| Stage2-vs-Stage3 |
9.371200E-01 |
| Stage2-vs-Stage4 |
2.153000E-01 |
| Stage3-vs-Stage4 |
9.516400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.94289029309402E-14 |
| Normal-vs-AfricanAmerican |
1.79901999999288E-05 |
| Normal-vs-Asian |
6.73940014905838E-10 |
| Caucasian-vs-AfricanAmerican |
9.321400E-01 |
| Caucasian-vs-Asian |
7.491400E-01 |
| AfricanAmerican-vs-Asian |
9.323200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.79234405095485E-12 |
| Normal-vs-Female |
1.67355018731996E-12 |
| Male-vs-Female |
6.388400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.26280097489939E-11 |
| Normal-vs-Age(41-60Yrs) |
1.87627691161651E-14 |
| Normal-vs-Age(61-80Yrs) |
4.29119961786739E-10 |
| Normal-vs-Age(81-100Yrs) |
2.084200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.324600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.063400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.026800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.073600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.889000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.801600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.618300E-03 |
| Classical-VS-Follicular |
3.512600E-01 |
| Classical-VS-Other |
1.036020E-01 |
| Classical-VS-Normal |
4.41360004099778E-09 |
| Tall-VS-Follicular |
9.140500E-02 |
| Tall-VS-Other |
7.279000E-01 |
| Tall-VS-Normal |
2.39289699166534E-11 |
| Follicular-VS-Other |
1.258180E-01 |
| Follicular-VS-Normal |
1.80610000288794E-08 |
| Other-VS-Normal |
1.980560E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.35629310402419E-12 |
| Normal-vs-N1 |
1.69339986477723E-10 |
| N0-vs-N1 |
4.140000E-01 |
|
|
